Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 3Withdrawn 2Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Cholangiocarcinoma 1Ann Arbor Stage II Mantle Cell Lymphoma 1

Interventions

Leucovorin 5Gemcitabine 5Fluorouracil 5Cisplatin 5durvalumab 3Oxaliplatin 3Capecitabine 3pembrolizumab 2lenvatinib 2S 1 (combination) 2Irinotecan 2Folfox protocol 2zimberelimab 1tocilizumab 1tislelizumab 1surufatinib 1regorafenib 1pemigatinib 1neratinib 1fludarabine 1donafenib 1dehydroftorafur 1Surgical Procedures, Operative 1Radiotherapy 1Proton Therapy 1Platinum 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Immune Checkpoint Inhibitors 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Cholangiocarcinoma × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT07619313 2026-06-04

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

Jonsson Comprehensive Cancer Center

Phase 1 Not yet recruiting
46 enrolled
Gastrointestinal

Pancreatic Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡